THE CLINICAL-PHARMACOLOGY OF METHOTREXATE

被引：113

作者：

SCHORNAGEL, JH ^{[1
]}

MCVIE, JG ^{[1
]}

机构：

[1] NETHERLANDS CANC INST,CLIN RES UNIT,1066 CX AMSTERDAM,NETHERLANDS

来源：

关键词：

D O I：

10.1016/S0305-7372(83)80032-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：53 / 75

页数：23

共 50 条

[11] CLINICAL-PHARMACOLOGY
BARNETT, JM
[J]. ARCHIVES OF DERMATOLOGY, 1993, 129 (09) : 1205 - 1205
[12] CLINICAL-PHARMACOLOGY
BRECKENRIDGE, A
[J]. LANCET, 1984, 1 (8380): : 796 - 797
[13] CLINICAL-PHARMACOLOGY
REIDENBERG, MM
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (21): : 1664 - 1665
[14] CLINICAL-PHARMACOLOGY
REIDENBERG, MM
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (23): : 3107 - 3109
[15] CLINICAL-PHARMACOLOGY
REIDENBERG, MM
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (19): : 2831 - 2832
[16] CLINICAL-PHARMACOLOGY - MEDICINE OR PHARMACOLOGY
SOMBERG, JC
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 32 (09): : 773 - 773
[17] CLINICAL-PHARMACOLOGY OF ORAL INTERMEDIATE-DOSE METHOTREXATE WITH OR WITHOUT PROBENECID
LILLY, MB
OMURA, GA
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 15 (03) : 220 - 222
[18] CONVENTIONAL AND HIGH-DOSE METHOTREXATE - CLINICAL-PHARMACOLOGY AND MECHANICS OF ACTION
JANKA, GE
[J]. WIENER MEDIZINISCHE WOCHENSCHRIFT, 1983, 133 : 6 - 12
[19] PHARMACOLOGY AND CLINICAL-PHARMACOLOGY OF VIGABATRIN
RICHENS, A
[J]. JOURNAL OF CHILD NEUROLOGY, 1991, 6 : S7 - S10
[20] THE PHARMACOLOGY AND CLINICAL-PHARMACOLOGY OF INDAPAMIDE
CAMPBELL, DB
MOORE, RA
[J]. POSTGRADUATE MEDICAL JOURNAL, 1981, 57 : 7 - 17